neurodevelopment

Folic Acid Supplementation: When to Start? How Long to Continue?

Folic acid supplementation before and during early pregnancy substantially reduces the risk of neural tube defects. Emerging research suggests that folic acid may have beneficial effects on neurodevelopment that extend beyond the first trimester. We review the evidence on the timing of folic acid supplementation and findings from the FASSTT randomized controlled trial, which examined whether supplementation during the second and third trimesters was associated with improved cognitive outcomes in children.

By |2026-09-15T10:47:35-04:00September 16th, 2026|Child Outcomes, Postpartum Psychiatric Disorders, Pregnancy & Medications|Comments Off on Folic Acid Supplementation: When to Start? How Long to Continue?

Essential Reads: Prenatal Exposure to Valproate and Risk of Neurodevelopmental Disorders in Offspring

Prenatal exposure to valproate is linked to increased risk of autism spectrum disorder, ADHD, lower IQ, and intellectual disability, especially at higher doses.

By |2025-10-09T10:59:46-04:00September 30th, 2025|Essential Reads, Medications and Pregnancy|Comments Off on Essential Reads: Prenatal Exposure to Valproate and Risk of Neurodevelopmental Disorders in Offspring

Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.

By |2023-10-03T12:00:00-04:00October 11th, 2023|ADHD Medications, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

New Study Investigates the Impact of Prenatal SSRI Exposure on Brain Structure in Older Children

Maternal SSRI use during pregnancy may be associated with altered brain development in children; however, this study cannot fully rule out contributions of confounding genetic and enviromental factors.

By |2024-06-26T13:12:36-04:00September 27th, 2023|Long-Term Outcomes, Outcomes, Pregnancy & Medications|Comments Off on New Study Investigates the Impact of Prenatal SSRI Exposure on Brain Structure in Older Children

Largest Study Ever Shows No Increase in Risk of Neurodevelopmental Disorders in Kids Exposed to Antidepressants In Utero

Analyzing data from nearly 150,000 children with prenatal antidepressant exposure in two healthcare databases, a recent study finds no association between prenatal exposure to antidepressants and risk for neurodevelopmental disorders.

By |2022-12-26T13:38:45-04:00October 12th, 2022|Antidepressants, Neurodevelopmental Disorders, Pregnancy & Medications, Prevalence & Risk Factors|Comments Off on Largest Study Ever Shows No Increase in Risk of Neurodevelopmental Disorders in Kids Exposed to Antidepressants In Utero

Maternal Adverse Childhood Experiences Linked to Changes in Neonatal Brain Development and Behavior

Maternal ACEs were associated with both newborn amygdala volume and subsequent infant negative emotionality.

By |2022-09-29T13:57:02-04:00October 4th, 2022|Child Outcomes, Psychiatric Disorders During Pregnancy, PTSD and Stress Related Disorders|Comments Off on Maternal Adverse Childhood Experiences Linked to Changes in Neonatal Brain Development and Behavior
Go to Top